Abstract
Burkitt lymphoma (BL) is a highly aggressive B cell non-Hodgkin lymphoma that has a high proliferation rate. The prognosis for BL is generally favorable, with cure rate of 75–90 % with modern chemoimmunotherapy regimens. Prompt administration of multiagent immunochemotherapy regimens is critical, because BL is almost always fatal if left untreated. Nevertheless here we report a case of BL that is still in complete remission after more than 4 years without any further treatment after surgical excision of the involved lymph node.
This is a preview of subscription content, log in via an institution to check access.
References
Linch DC (2012) Burkitt lymphoma in adults. Br J Haematol 156(6):693–703
Jacobson C, LaCasce A (2014) How I treat Burkitt lymphoma in adults. Blood 124(19):2913–2920
Burkitt DP, Kyalwazi SK (1967) Spontaneous remission of African lymphoma. Br J Cancer 21(1):14–16
David J, Burkitt D (1968) Burkitt’s lymphoma: remissions following seemingly non-specific therapy. Br Med J 4(5626):288–289
Bluming AZ, Ziegler JL (1971) Regression of Burkitt’s lymphoma in association with measles infection. Lancet 2(7715):105–106
Sarkodee-Adoo C, Pittarelli L, Jaffe E, Sorbara L, Raffeld M, Yao X, Haddad R, Heller T (2001) Regression and clonally distinct recurrence of human immunodeficiency virus related Burkitt-like lymphoma during antiretroviral therapy. Leuk Lymphoma 42(5):1125–1131
Parekh S, Hebert T, Ratech H, Sparano J (2005) Variable problems in lymphomas: CASE 3. Spontaneous regression of HIV-associated Burkitt’s lymphoma of the cecum. J Clin Oncol 23(31):8116–8117
Baumgaertner I, Copie-Bergman C, Levy M, Haioun C, Charachon A, Baia M, Sobhani I, Delchier JC (2009) Complete remission of gastric Burkitt’s lymphoma after eradication of Helicobacter pylori. World J Gastroenterol 15(45):5746–5750
Costa LJ, Xavier AC, Wahlquist AE, Hill EG (2013) Trends in survival of patients with Burkitt lymphoma/leukemia in the USA: an analysis of 3691 cases. Blood 121(24):4861–4866
Intermesoli T, Rambaldi A, Rossi G, Delaini F, Romani C, Pogliani EM, Pagani C, Angelucci E, Terruzzi E, Levis A, Cassibba V, Mattei D, Gianfaldoni G, Scattolin AM, Di Bona E, Oldani E, Parolini M, Gökbuget N, Bassan R (2013) High cure rates in Burkitt lymphoma and leukemia: a Northern Italy Leukemia Group study of the German short intensive rituximab-chemotherapy program. Haematologica 98(11):1718–1725
Acknowledgments
The authors thank Professor Metin Ozdemirli, MD, Ph.D for revision of the pathological specimens and Professor Ahmet Dogan, MD, Ph.D for revision of the pathological specimens and performing in situ hybridization for EBER of this case report. Written informed consent was obtained from the patient for publication of this manuscript and accompanying images.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
There is no funding to be reported about this work.
Conflict of interest
All of the authors declare that he/she has no conflict of interest.
Informed Consent
Informed consent was obtained from all individual participants included in the study.
Rights and permissions
About this article
Cite this article
Bekoz, H.S., Kantarcioglu, B., Tecimer, T. et al. Complete Remission of Burkitt Lymphoma After Surgical Excision: A Case Report. Indian J Hematol Blood Transfus 32 (Suppl 1), 178–180 (2016). https://doi.org/10.1007/s12288-016-0650-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12288-016-0650-6